Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Toxicology. 2023 Nov 22;500:153677. doi: 10.1016/j.tox.2023.153677

Fig. 2.

Fig. 2.

4-52, a human-relevant PCB 52 metabolite (Shimada et al., 2016), was continuously released in vitro from implants containing 0 (sham), 1, 5, or 10% of 4-52 over 28 days. The percentage of 4-52 released is shown for both (A) daily and (B) cumulative release from the implants. These implants were incubated in PBS with 10% bovine calf serum at 37 °C. Data are expressed as mean ± standard deviation (n=3).